Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation-Reference-Cited by-同舟云学术

Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation

Published:2021-04-19 Issue:16 Volume:127 Page:2916-2925
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Guo Theresa W.¹²^ORCID,Saiyed Faiez¹³,Yao Christopher M. K. L.¹^ORCID,Kiong Kimberley L.¹^ORCID,Martinez Julian¹,Sacks Ruth⁴,Lee J. Jack⁵,Moreno Amy C.⁶^ORCID,Frank Steven J.⁶,Rosenthal David I.⁶,Glisson Bonnie S.⁴,Ferrarotto Renata⁴^ORCID,Mott Frank E.⁴,Johnson Faye M.⁴⁷,Myers Jeffrey N.¹⁷

Affiliation:

1. Department of Head and Neck Surgery The University of Texas MD Anderson Cancer Center Houston Texas

2. Division of Otolaryngology–Head and Neck Surgery, Department of Surgery University of California San Diego California

3. Department of Otorhinolaryngology University of Maryland School of Medicine Baltimore Maryland

4. Department of Thoracic Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Biostatistics Division of Basic Sciences The University of Texas MD Anderson Cancer Center Houston Texas

6. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas

7. Graduate School of Biomedical Sciences University of Texas Houston Texas

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33491

Reference30 articles.

1. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

2. Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

3. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

4. Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

5. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer;Cancer Medicine;2023-01-27

2. Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma;Clinical Cancer Research;2023-01-23

3. Dr. PA Shah Oration 2022;J HEAD NECK PHYSICIA;2023

4. Examination of optimal initial treatment for Stage Ⅲ p16-positive oropharyngeal squamous cell carcinoma;JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY;2023